A Phase 2/3 interventional study of Cefepime and Cefuroxime plus Metronidazole in Emergency Cesarean Section and Infection Wound, sponsored by Assiut University. Status unknown at 1 site in Egypt. Open to female participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-07-05.
Sponsored by Assiut University · Phase 2/3, Interventional, and Prevention
Compare between cefepime versus routine antibiotics as a prophylactic antibiotic during emergency cesarean section in a tertiary center of obstetric care
This is a randomized double blinded study which compare between single dose cefepime versus cefuroxime plus metronidazole during emergency intrapartum cesarean section.
Outcomes will include fever, wound infection, and urinary tract infection.
1,692 studies on the registry are indexed under Emergencies; 333 are open to participants now.
This study's planned enrollment of 500 is above the median of 145 across 931 interventional studies indexed under Emergencies.
Browse Emergencies studies →Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.
Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patient will receive "Cefepime" ,"Maxipime®" 1 gm IV during cesarean section just before skin incision
Drug: Cefepime
Patient will receive "Cefuroxime", "Zinnat®" 1gm ,and "metronidazole"Flagyl®" 500 IV; just before skin incision for emergency cesarean section
Drug: Cefuroxime plus Metronidazole
Antibiotic prophylaxis
Also known as: Maxipime
Antibiotic prophylaxis
Also known as: Zinnat plus Flagyl
Incidence of surgical site wound infection
Examining the wound after one week of the surgery to detect any infection
Time frame: one week
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assiut University